Pricing Log in Create free account

NeuroOne Medical Technologies Corporation (NMTC) vs Telesis Bio Inc. (TBIO)

NeuroOne Medical Technologies Corporation and Telesis Bio Inc. are both Medical Devices companies. NeuroOne Medical Technologies Corporation is the larger, with a market value of $7.8M against $5.3M — 1.5× the size. NeuroOne Medical Technologies Corporation grew revenue faster over the last twelve months: 42.8% against −54.9%. NeuroOne Medical Technologies Corporation has the higher net margin (−78.6% vs −354.1%) and the lower return on invested capital (−287.1% vs 0.00%). Across the 17 metrics below, Telesis Bio Inc. leads on 9 and NeuroOne Medical Technologies Corporation on 8.

Valuation

Metric NMTC TBIO Medical Devices median
P/E n/m n/m 24.94
P/S 0.78 0.00 2.66
P/B 1.95 n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 0.56 0.12 2.76
Earnings yield (109.41%) (282,010.00%) (12.66%)
Free cash flow yield (97.27%) (134,495.21%) (7.18%)

Profitability

Metric NMTC TBIO Medical Devices median
Gross margin 55.65% 56.11% 57.76%
Operating margin (83.43%) (326.88%) (14.84%)
Net margin (78.63%) (354.14%) (14.45%)
Free cash flow margin (75.63%) (176.21%) (5.70%)
Return on equity (124.66%) 1,013.88% (10.56%)
Return on assets (87.56%) (73.87%) (17.26%)
Return on invested capital (287.08%) 0.00% (5.22%)

Growth

Metric NMTC TBIO Medical Devices median
Revenue growth (TTM) 42.83% (54.89%) 10.41%
EPS growth (last fiscal year) 80.43% 0.61% 28.17%
Revenue growth, 5-year CAGR 36.40% 41.76% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NMTC TBIO Medical Devices median
Debt to equity 0.00 (0.23) 0.04
Current ratio 2.84 1.23 2.67
Net debt to EBITDA 1.74 0.46 0.54

Dividend

Metric NMTC TBIO Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric NMTC TBIO Medical Devices median
Market cap 7.84m 5.31m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack